André Tavares da Silva-Fernandes

Dr. André Tavares da Silva-Fernandes


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2022 in Viruses
Verified
Journal Article
Open access
PDF file
RMRafaella Miranda Moraes
Rafaella Miranda Moraes
RFRosilainy Surubi Fernandes
Rosilainy Surubi Fernandes
ASAndré Tavares da Silva-Fernandes
André Tavares da Silva-Fernandes
AFAnielly Ferreira-de-Brito
Anielly Ferreira-de-Brito
SMSilvia Bahadian Moreira
Silvia Bahadian Moreira
RLRicardo Lourenço-de-Olveira
Ricardo Lourenço-de-Olveira
Beside humans, thousands of non-human primates (NHPs) died during the recent outbreak caused by the yellow fever virus (YFV) in Brazil. Vaccination of NHPs against YFV with the YF 17DD attenuated virus has emerged as a public health strategy, as it would reduce sylvatic transmission while also preserving endangered susceptible species. The hypothesis of establishing an uncontrolled transmission of this attenuated virus in nature was raised. We assessed vector competence of four sylvatic mosquito species, Haemagogus leucocelaenus, Haemagogus janthinomys/capricornii, Sabethes albiprivus, and Sabethes identicus, as well as the urban vector Aedes aegypti for YF 17DD attenuated vaccine virus when fed directly on eleven viremic lion tamarins or artificially challenged with the same virus. No infection was detected in 689 mosquitoes engorged on viremic lion tamarins whose viremia ranged from 1.05 × 103 to 6.61 × 103 FFU/mL, nor in those artificially taking ≤ 1 × 103 PFU/mL. Low viremia presented by YF 17DD-vaccinated New World NHPs combined with the low capacity and null dissemination ability in sylvatic and domestic mosquitoes of this attenuated virus suggest no risk of its transmission in nature. Thus, vaccination of captive and free-living NHPs against YFV is a safe public health strategy.